IMO throwing out sales projeciions at this point in time is a bit risky as we all know that the market punishes companies that don't meet targets. Although I know where u r coming from Russ u only have to look at GTG which I own and a slow uptake in their Brevagen product in the US (new sales figures due soon) initially has seen the SP wane over the last few months. Although I am hopeful of a much better result this qtr if it is not as good as expected the SP will get smashed.
We all know AHZ has good products and is of the best bios around
Baby Steps....all IMO DYOR
why sell now will miss shares at 0.05 cents, page-45
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.85 |
Change
0.860(8.61%) |
Mkt cap ! $229.3M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.90 | $10.00 | $498.3K | 46.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 480 | $10.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.88 | 87 | 1 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |